Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Bank OZK
OZK
$5.63B
| $80.2M | 0.08% |
2,836,046
+771,526
| +37% | +$20M |
|
227
Evercore
EVR
$11.8B
| $79.5M | 0.08% |
1,330,039
-23,071
| -2% | -$1.23M |
|
228
General Motors
GM
$81.5B
| $79.1M | 0.08% |
1,935,646
+433,041
| +29% | +$16.4M |
|
229
Clearway Energy Class C
CWEN
$4.77B
| $78.1M | 0.08% |
3,903,032
+474,768
| +14% | +$8.46M |
|
230
Sprouts Farmers Market
SFM
$7.5B
| $78M | 0.08% |
2,030,398
+1,293,922
| +176% | +$54.7M |
|
|
RDC
231
DELISTED
Rowan Companies Plc
RDC
| $78M | 0.08% |
2,204,778
-44,958
| -2% | -$1.61M |
|
232
Enbridge
ENB
$121B
| $77.6M | 0.08% |
1,776,464
-3,458,425
| -66% | -$146M |
|
|
CQH
233
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $77.4M | 0.08% |
+4,126,518
| New | +$78.7M |
|
234
AbbVie
ABBV
$471B
| $77M | 0.08% |
+1,457,742
| New | +$71.6M |
|
235
Thermo Fisher Scientific
TMO
$213B
| $76.9M | 0.08% |
690,519
| – | – |
|
236
Terex
TEX
$7.56B
| $76.8M | 0.08% |
1,828,227
+64,747
| +4% | +$2.35M |
|
237
Tractor Supply
TSCO
$16.4B
| $76.6M | 0.08% |
4,934,885
-38,480
| -0.8% | -$550K |
|
238
ServiceNow
NOW
$120B
| $76.3M | 0.07% |
6,811,755
+2,367,460
| +53% | +$25M |
|
239
Ionis Pharmaceuticals
IONS
$9.04B
| $76M | 0.07% |
1,907,383
-5,710
| -0.3% | -$203K |
|
240
Herc Holdings
HRI
$4.83B
| $76M | 0.07% |
884,861
+60,819
| +7% | +$4.34M |
|
241
Iron Mountain
IRM
$36.4B
| $75.7M | 0.07% |
2,698,614
-887,480
| -25% | -$22.7M |
|
242
Wintrust Financial
WTFC
$10.8B
| $75M | 0.07% |
1,625,641
-79,921
| -5% | -$3.54M |
|
243
CMS Energy
CMS
$23B
| $74M | 0.07% |
2,763,233
| – | – |
|
244
Global Payments
GPN
$24B
| $73.8M | 0.07% |
2,269,640
-45,010
| -2% | -$1.36M |
|
|
CSOD
245
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $73.3M | 0.07% |
1,373,489
+598,209
| +77% | +$29.7M |
|
|
MINI
246
DELISTED
Mobile Mini Inc
MINI
| $72.6M | 0.07% |
1,763,917
-82,075
| -4% | -$3.06M |
|
247
Eversource Energy
ES
$28.1B
| $72.2M | 0.07% |
1,702,455
| – | – |
|
|
TFM
248
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $72.1M | 0.07% |
+1,779,116
| New | +$82.7M |
|
249
Cheesecake Factory
CAKE
$4.98B
| $70.2M | 0.07% |
1,454,586
-874,390
| -38% | -$40.9M |
|
|
SBNY
250
DELISTED
Signature Bank
SBNY
| $69.7M | 0.07% |
649,206
-77,804
| -11% | -$7.96M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.